This week, Alphabet Inc. (NASDAQ: GOOGL) will split its shares, making it available to a broader variety of ordinary investors. Could this be the start
Accenture plc (NYSE: ACN), a consulting and outsourcing corporation, exceeded Wall Street analysts’ projections for revenue growth in the most recent quarter. Despite that, the
Couchbase, Inc. (NASDAQ: BASE), a database technology provider, released a positive report for the first quarter of fiscal 2023. The company reports double-digit growth in
Eli Lilly & Company (NYSE: LLY) has won clearance to market tirzepatide, a medicine that has the potential to change diabetes treatment. On May 17,
Qualcomm Incorporated (NASDAQ: QCOM) has released its second-quarter report for the fiscal year 2022. The stock surpassed Wall Street projections by a wide margin, and
Kintara Therapeutics, Inc. (KTRA), a clinical-stage drug development company, closed Monday’s regular trading session at $0.50 after rocketing by 35.41% during the day. In the
Aurora Cannabis Inc. (ACB), a company involved in the cannabis business, has gained an increase of 6.25% in the premarket trading session. Consequently, ACB was
Futu Holdings Ltd. (FUTU), a company that operates an online wealth management platform, has slid 5.11% in the premarket trading session. Consequently, FUTU stock was
Orphazyme A/S (ORPH), a biopharmaceutical company, is nose-diving in the premarket trading session. The stock has slumped 36.51% and consequently was trading at $0.80 when
Blonder Tongue Laboratories, Inc. (BDR), a technology development and manufacturing company, has ascended 10.72% in the premarket trading session. Consequently, the stock was trading at